Advances in our understanding of allergic inflammation have led to the development of
several novel anti-inflammatory drugs that target specific aspects of the inflammatory
process. These treatments are based on improvements in existing therapies or on a better
understanding of the cellular and molecular mechanisms involved in atopic diseases.
Although most attention has been focused on asthma, treatments that inhibit the atopic
disease process would have application to all atopic diseases, which often coincide …